277 related articles for article (PubMed ID: 2666433)
1. Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor.
Ashkenazi S; Cleary TG
J Clin Microbiol; 1989 Jun; 27(6):1145-50. PubMed ID: 2666433
[TBL] [Abstract][Full Text] [Related]
2. A method for detecting Shiga toxin and Shiga-like toxin-I in pure and mixed culture.
Ashkenazi S; Cleary TG
J Med Microbiol; 1990 Aug; 32(4):255-61. PubMed ID: 2391709
[TBL] [Abstract][Full Text] [Related]
3. Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.
Waddell T; Head S; Petric M; Cohen A; Lingwood C
Biochem Biophys Res Commun; 1988 Apr; 152(2):674-9. PubMed ID: 3284526
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
Jacewicz M; Clausen H; Nudelman E; Donohue-Rolfe A; Keusch GT
J Exp Med; 1986 Jun; 163(6):1391-404. PubMed ID: 3519828
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of enzyme-linked immunosorbent assays for detection of shiga-like toxin I and shiga-like toxin II.
Downes FP; Green JH; Greene K; Strockbine N; Wells JG; Wachsmuth IK
J Clin Microbiol; 1989 Jun; 27(6):1292-7. PubMed ID: 2666439
[TBL] [Abstract][Full Text] [Related]
6. Verotoxin receptor glycolipid in human renal tissue.
Boyd B; Lingwood C
Nephron; 1989; 51(2):207-10. PubMed ID: 2644572
[TBL] [Abstract][Full Text] [Related]
7. Sensitive receptor-specified enzyme-linked immunosorbent assay for Escherichia coli verocytotoxin.
Basta M; Karmali M; Lingwood C
J Clin Microbiol; 1989 Jul; 27(7):1617-22. PubMed ID: 2671020
[TBL] [Abstract][Full Text] [Related]
8. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities.
Strockbine NA; Marques LR; Newland JW; Smith HW; Holmes RK; O'Brien AD
Infect Immun; 1986 Jul; 53(1):135-40. PubMed ID: 3522426
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of a phage-encoded cytotoxin from an Escherichia coli O111 strain associated with hemolytic-uremic syndrome.
Karch H; Bitzan M
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):41-51. PubMed ID: 2464885
[TBL] [Abstract][Full Text] [Related]
10. The association of Shiga toxin and other cytotoxins with the neurologic manifestations of shigellosis.
Ashkenazi S; Cleary KR; Pickering LK; Murray BE; Cleary TG
J Infect Dis; 1990 May; 161(5):961-5. PubMed ID: 2324546
[TBL] [Abstract][Full Text] [Related]
11. Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.
Cooling LL; Walker KE; Gille T; Koerner TA
Infect Immun; 1998 Sep; 66(9):4355-66. PubMed ID: 9712788
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of the rabbit intestinal glycolipid receptor for Shiga toxin. Further evidence for the developmental regulation of globotriaosylceramide in microvillus membranes.
Mobassaleh M; Gross SK; McCluer RH; Donohue-Rolfe A; Keusch GT
Gastroenterology; 1989 Aug; 97(2):384-91. PubMed ID: 2663611
[TBL] [Abstract][Full Text] [Related]
13. Human milk contains the Shiga toxin and Shiga-like toxin receptor glycolipid Gb3.
Newburg DS; Ashkenazi S; Cleary TG
J Infect Dis; 1992 Oct; 166(4):832-6. PubMed ID: 1527419
[TBL] [Abstract][Full Text] [Related]
14. Digalactosyl-containing glycolipids as cell surface receptors for shiga toxin of Shigella dysenteriae 1 and related cytotoxins of Escherichia coli.
Brown JE; Echeverria P; Lindberg AA
Rev Infect Dis; 1991; 13 Suppl 4():S298-303. PubMed ID: 2047653
[TBL] [Abstract][Full Text] [Related]
15. Anticytotoxin-neutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome.
Ashkenazi S; Cleary TG; Lopez E; Pickering LK
J Pediatr; 1988 Dec; 113(6):1008-14. PubMed ID: 3057156
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic aspects of Shiga-like toxin production in traditional enteropathogenic Escherichia coli.
Bitzan M; Karch H; Maas MG; Meyer T; Rüssmann H; Aleksić S; Bockemühl J
Zentralbl Bakteriol; 1991 Jan; 274(4):496-506. PubMed ID: 1863318
[TBL] [Abstract][Full Text] [Related]
17. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin.
Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ
J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402
[TBL] [Abstract][Full Text] [Related]
18. DNA probes for Shiga-like toxins I and II and for toxin-converting bacteriophages.
Newland JW; Neill RJ
J Clin Microbiol; 1988 Jul; 26(7):1292-7. PubMed ID: 2842369
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.
Tesh VL; Samuel JE; Perera LP; Sharefkin JB; O'Brien AD
J Infect Dis; 1991 Aug; 164(2):344-52. PubMed ID: 1649877
[TBL] [Abstract][Full Text] [Related]
20. Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli.
O'Brien AD; LaVeck GD; Thompson MR; Formal SB
J Infect Dis; 1982 Dec; 146(6):763-9. PubMed ID: 6754826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
